, Tracking Stock Market Picks
Enter Symbol:

up 17.11 %


Posted on: Thursday,  Oct 11, 2007  11:25 AM ET by HSBC Securities

HSBC Securities rated Buy INSULET CORPORATION (NASDAQ: PODD) on 10/11/2007, when the stock price was $25.06. Since
then, INSULET CORPORATION has gained 17.12% as of 01/11/2016's recent price of $29.35.
If you would have followed this HSBC Securities's recommendation on PODD, you would have gained 17.11% of your investment in 3014 days.

Insulet Corporation is a medical device company that develops, manufactures and markets insulin infusion system for people with insulin-dependent diabetes. The Company?s OmniPod Insulin Management System (OmniPod System) consists of its OmniPod disposable insulin infusion device and its handheld, wireless Personal Diabetes Manager. The United States Food and Drug Administration have approved the OmniPod System for sale in the United States.

HSBC has refined and refocused its Global Equities organisation, creating a lean and flexible business model built to meet the needs of global issuers and investors today and in the future. Acknowledging the changing demands of clients, we have also refined our research model, moving away from traditional maintenance to focus on long term, thematic research (a two-year-plus horizon) combined with short term (zero to three months), real-time, actionable ideas both for companies and sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/11/2007 11:25 AM Buy
25.06 33.00
as of 8/27/2015
1 Week down  -13.39 %
1 Month down  -5.44 %
3 Months up  7.70 %
1 YTD down  -20.88 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy